1. Home
  2. IOVA vs TNET Comparison

IOVA vs TNET Comparison

Compare IOVA & TNET Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Iovance Biotherapeutics Inc.

IOVA

Iovance Biotherapeutics Inc.

HOLD

Current Price

$4.09

Market Cap

1.6B

Sector

Health Care

ML Signal

HOLD

Logo TriNet Group Inc.

TNET

TriNet Group Inc.

HOLD

Current Price

$42.29

Market Cap

1.7B

ML Signal

HOLD

Company Overview

Basic Information
Metric
IOVA
TNET
Founded
2007
1988
Country
United States
United States
Employees
N/A
2700
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Business Services
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
1.6B
1.7B
IPO Year
2008
2000

Fundamental Metrics

Financial Performance
Metric
IOVA
TNET
Price
$4.09
$42.29
Analyst Decision
Buy
Hold
Analyst Count
10
5
Target Price
$9.00
$65.80
AVG Volume (30 Days)
13.1M
350.1K
Earning Date
05-07-2026
04-30-2026
Dividend Yield
N/A
2.57%
EPS Growth
14.84
N/A
EPS
N/A
1.90
Revenue
N/A
$5,010,000,000.00
Revenue This Year
$47.74
N/A
Revenue Next Year
$40.31
$3.30
P/E Ratio
N/A
$21.96
Revenue Growth
N/A
N/A
52 Week Low
$1.67
$33.67
52 Week High
$5.63
$84.08

Technical Indicators

Market Signals
Indicator
IOVA
TNET
Relative Strength Index (RSI) 61.90 54.20
Support Level $2.05 $34.47
Resistance Level $4.27 $46.38
Average True Range (ATR) 0.27 2.04
MACD 0.03 -0.06
Stochastic Oscillator 87.50 59.60

Price Performance

Historical Comparison
IOVA
TNET

About IOVA Iovance Biotherapeutics Inc.

Iovance Biotherapeutics Inc is a clinical-stage biopharmaceutical company, pioneering a transformational approach to treating cancer by harnessing the human immune system's ability to recognize and destroy diverse cancer cells using therapies personalized for each patient. The company is preparing for potential U.S. regulatory approvals and commercialization of the first autologous T-cell therapy to address a solid tumor cancer. It operates in one segment, focusing on innovating, developing, and commercializing therapies using its autologous TIL cell therapies for patients with solid tumor cancers. Geographically, the company operates in United States and Rest of the World.

About TNET TriNet Group Inc.

Trinet Group Inc provides human resources solutions for small and medium-sized businesses through technology-enabled services. Its offerings include human capital expertise, employee benefits such as health insurance and retirement plans, payroll and payroll tax administration, risk mitigation, and compliance consulting. The company provides its services through professional employer organization (PEO) services delivered via a co-employment model, as well as administrative services organization (ASO) offerings. The majority of the company's revenue is derived from the insurance-related billings and administrative fees collected from PEO clients.

Share on Social Networks: